Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
MPI-CDG
MPI-CDG is a form of congenital disorders of N-linked glycosylation, characterized by cyclic vomiting, profound hypoglycemia, failure to thrive, liver fibrosis, gastrointestinal complications (protein-losing enteropathy with hypoalbuminaemia, life-threatening intestinal bleeding of diffuse origin), and thrombotic events (protein C and S deficiency, low anti-thrombin III levels), whereas neurological development and cognitive capacity is usually normal. The clinical course is variable even within families. The disease is caused by loss of function of the gene MPI (15q24.1).
ORPHA:79319
Classification level: Disorder
- CDG syndrome type Ib
- CDG-Ib
- CDG1B
- Carbohydrate deficient glycoprotein syndrome type Ib
- Congenital disorder of glycosylation type 1b
- Congenital disorder of glycosylation type Ib
- Phosphomannose isomerase deficiency
Prevalence: <1 / 1 000 000
Inheritance: Autosomal recessive
Age of onset: Infancy, Neonatal
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
General public
Guidelines
Disease review articles
Genetic testing
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Newborn screening